Rachel's Licence Portfolio
An improved SARS-CoV-2 spike protein subunit (S1) antigen and two exceptional ELISA assay formats for highly specific and sensitive serological detection and measurement of antibodies to SARS-CoV-2
18F-FET-βAG-TOCA is a novel, ‘click’ 18F-labelled octreotate PET imaging radiopharmaceutical that detects tumour lesions in patients with neuroendocrine tumours (NETs).
A simple, whole blood 2-gene expression signature that distinguishes bacterial infection from both viral infection and childhood inflammatory diseases.
A novel tracer, 18F-ICMT-11, targeting specific biological processes to improve detection of tumours that are often missed by FDG PET imaging
A tool for predicting Alzheimer’s Disease (AD) with greater accuracy than conventional methods.
A tool for predicting risk profile in patients with pre-existing cardiac dysfunction with greater accuracy than the current gold standard
Small molecule inhibitors for treatment of solid tumours